ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sutimlimab shows promise for hard-to-treat, rare blood disorder
December 19, 2018In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments. -
Sangamo, Pfizer Announce First Patient Receives SB-525 Treatment in Clinical Trial
August 28, 2017Sangamo Therapeutics and Pfizer announced the first patient received treatment in the Phase 1/2 clinical trial (Alta trial) evaluating SB-525, an investigational gene therapy for patients with Hemophilia A, a rare genetic blood disorder. -
First patient cured of rare blood disorder
March 22, 2017Using a technique that avoids the use of high-dose chemotherapy and radiation in preparation for a stem cell transplant...
Pharma Sources Insight January 2025
